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evaluated patterns of use of TJA following an index primary TJA over an
8-year period.
Methods: Primary and revision TJA procedures performed on Ontario,
Canada, residents aged 55+ years between April 2002 (baseline) and
March 2010 were identiﬁed from hospital discharge abstracts using
speciﬁc ICD-10-CA/CCI procedure and diagnosis codes. The records of
individuals who underwent TJA prior to April 1, 2002 (i.e. pre-baseline)
were excluded as were non-elective TJAs and those performed for
cancer, fractures or trauma. Due to our speciﬁc interest in examining
the patterns of use of TJA for OA, we also excluded individuals who
received their ﬁrst TJA before age 55 years. Of those aged 55+ years
who received their ﬁrst (index) TJA following April 2002, we examined
the proportions with repeat hospitalizations for TJA, and the associated
TJA type (elective versus non-elective, hip versus knee, primary versus
revision). The maximum follow-up time was 8 years.
Results: Excluding those with a pre-baseline TJA, 164,330 index TJA
procedures were identiﬁed. Of these, 129,937 were eligible for inclusion
(90.4% of TJAs performed in people aged 55+ years). Bilateral knee
replacements in the same hospitalization were more frequent (n = 4,460,
3.44%) than were bilateral hip replacements (n = 228, 0.18%). Further,
knee replacements as the ﬁrst TJA were almost twice as common
as hip replacements (65.85% versus 34.15%). A total of 33,474 second
TJA hospitalizations occurred (25.76% index TJAs were followed by a
second TJA hospitalization during the observation period). Of 85,565
index primary knee replacements (4,460 bilateral), 23,984 (28.03%)
experienced a second TJA hospitalization, with a median duration (IQR)
from the index procedure of 1.37 years (0.63–2.93 years). Of these, 83.68%
were for primary TJA of the contra-lateral knee, 1,802 (7.51%) were single
or bilateral primary hip replacements, and 2,087 (8.7%) were for revision
or one or both index knees. Of 44,372 index primary hip replacements
(228 bilateral), 9,490 (21.39%) experienced a second TJA hospitalization
with a median duration of 1.21 years (0.64–2.58 years) from the index
procedure. Of these, 69.52% were for primary TJA of the contra-lateral
hip, 2,193 (23.11%) were single or bilateral primary knee replacements,
and 700 (7.38%) were for revision or one or both index hips. Of those
who experienced a second TJA hospitalization, 2,561 (1.97% of the cohort)
went on to receive a third within a median duration of 2.8 years (IQR
1.1–4.1 years) from the index procedure; the majority (89.54%) of these
were elective TJAs.
Conclusions: In a population cohort undergoing primary hip or knee
TJA, repeat TJA hospitalizations are frequent; approximately one-
quarter experienced a second TJA hospitalization, which was most
often for primary TJA of the contra-lateral hip or knee. Most repeat
hospitalizations occurred within 3 years of the index TJA. Together, these
data suggest that exclusion of such individuals from TJA cohort studies
reduces the generalizability of results to all patients undergoing primary
TJA. Researchers are encouraged to incorporate these subsequent TJA
hospitalizations in examining the risks and beneﬁts of this common
procedure.
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Purpose: To examine the association of radiographic hip osteoarthritis
(RHOA) or total hip replacement (THR) with prevalent frailty status in
elderly men. Previous studies have shown that frailty is associated with
co-morbidities and increased mortality.
Methods: We conducted a cross-sectional study in the Osteoporotic
Fractures in Men (MrOS) Study, a cohort of 5994 men age ≥65 yrs.
at baseline. We included all men without prior hip fracture who had
a hip radiograph obtained at visit 2 (4.6±0.35 yrs from baseline) and
measurements for assessment of frailty status at visit 2. We deﬁned
frailty using the Fried deﬁnition as three or more of the following
components: unintentional weight loss deﬁned as >5% weight loss
from baseline to visit 2; weakness deﬁned as low grip strength; self-
reported exhaustion; low activity level, and slow walking speed. Men
with intermediate frailty status met one or two criteria while robust
men had none. We deﬁned RHOA as a modiﬁed Croft score≥2 on
hip radiograph. The relation of hip RHOA and RHOA and/or THR to
prevalence of frailty status was examined using the proportional odds
model adjusted for age, college education, and BMI ascertained at visit
2.
Results: We evaluated 4130 men with a mean age of 71.3(±5.4) years
and BMI of 27.4 (±4.0) Kg/m2. Of these, 415 had RHOA and 137 had
validated THR (41 with RHOA in one hip and THR in the contralateral
hip; 96 THRs with no OA in contralateral hip). Prevalence of robust,
intermediate and frailty status was 41%, 47%, and 11%, respectively.
RHOA was associated with greater severity of frailty status (multivariable
adjusted OR=1.24, 95% CI 1.01, 1.51). RHOA and/or THR was associated
with a higher odds of worse frailty status (OR=1.43, 95% CI 1.19, 1.72)
after multivariable adjustment. Further adjustment for self-reported
health status attenuated, but did not eliminate the association (OR=1.34,
95% CI 1.11, 1.62).
Conclusions: There is a moderate association of RHOA and THR with
frailty in elderly men. This ﬁnding suggests that interventions to reduce
frailty may be warranted in elderly men with either RHOA or THR.
339
EPIDEMIOLOGICAL ASPECTS OF OSTEOARTHRITIS (OA) IN THE LATIN
AMERICAN POPULATION: A FREQUENCY STUDY
H.L. Riera1, M. Vera1, R.A. Torres1, A. Reginato2, O. Jair Felipe3,
B. Roma´n3, O. D’Rillo3, M. Quintero1. 1Univ. de Los Andes, Me´rida,
Venezuela, Bolivarian Republic of ; 2The Warren Alpert Sch. of Med. at
Brown Univ., Providence, RI, USA; 3PANLAR OA Group, Me´rida, Venezuela,
Bolivarian Republic of
Purpose: The aim of the present study is to investigate epidemiological
aspects of Osteoarthritis (OA) in Latin American region.
Methods: A multi-center study was conducted in 13 Latin American
countries that included 3040 patients evaluated at rheumatology
outpatient clinics with deﬁned ACR criteria of Osteoarthritis (OA).
Epidemiologic aspects were collected using standardized questionnaire
between July 1st and September 30th 2010 time period.
Results: Approximately 3040 patients met OA criteria for this study. The
mean age of patients was 62.5 year-old. There was a 4.8:1 female/male
ratio. Mean Body Mass Index (BMI) was 28.7. Overweight (BMI> 25)
was seen in 79.4% while obesity (BMI > 30) in 38.1%. Approximately
88% of the patients had primary OA and the time of consultation with
diagnosis made within 5 years. Speciﬁc OA joint involvement: only knee
OA was seen in 948 patients (31.2%); only hands OA in 290 patients
(9.5%); hands and knee OA seen in 699 patients (22.9%); DIP and PIP
joint was found in 198 patients (6.5%); axial involvement (cervical and
lumbar spine) was seen, together in 202 patients (6.6%); and hip joint
involvement in 40 patients (1.3%). Radiographic severity of OA on the
basis of the Kellgren-Lawrence grading scale (0–4) showed that 88.5% of
patients had Kellgren-Lawrence grade 2 and 3. Treatments options for
OA included: NSAIDs (15%); paracetamol (4.1%); hyaluronic acid (4.4%);
glucosamine-sulphate (3.5%); glucosamine sulphate+chondroitin (5.2%);
glucosamine sulphate +chondroitin+NSAIDs (12.2%); and glucosamine
sulphate +chondroitin + others (5.8%). Comorbidities associated with
OA: none seen in 577 patients (19%); hypertension seen in 391 patients
(12.9%); hypertension+obesity in 284 patients (9.3%); obesity in
295 patients (9.7%); an osteoporosis seen in 118 patients (3.9%)
Conclusions: This is the ﬁrst Latin American study to evaluate the
frequency of OA in rheumatology outpatient setting. This study showed
strong correlation of OA with age greater rate among women than
men of the same age. In agreement with other epidemiological studies
BMI correlated with frequency of OA. Knees and hands were the most
frequently speciﬁc joints involved in OA. Treatment of OA between 13
countries showed a diverse spectrum ranging from a combination of
analgesic to chondroprotection and viscosupplementation. Hypertension
and obesity were two most common comorbid conditions more
frequently found in our patients. Our epidemiological ﬁndings are in
agreement with other epidemiological studies and provide a better
understanding of the factors contributing to the development of OA
in the Latin American population.
